The Interplay Between Cardiovascular Disease and Lung Cancer

Cardiovascular disease (CVD) and lung cancer are among the leading causes of mortality worldwide, with a significant interplay that complicates patient management and treatment outcomes. This review explores the complex relationship between various forms of CVD - such as coronary artery disease, hea...

Full description

Saved in:
Bibliographic Details
Published inCurēus (Palo Alto, CA) Vol. 16; no. 6; p. e62953
Main Authors Katic, Luka, Choi, James, Diaz Saravia, Sara, Silverman, Alexander, Nagourney, Alexander, Torelli, Vincent, Gupta, Soumya, Glavan, Martina, Gulati, Amit, Khurana, Sakshi, Tsyvkin, Elina
Format Journal Article
LanguageEnglish
Published United States Cureus Inc 23.06.2024
Cureus
Subjects
Angina pectoris
Beta blockers
Cancer therapies
Cardiac arrhythmia
Cardiology
Cardiovascular disease
Cardioversion
Chronic illnesses
Congenital diseases
Coronary vessels
Coronaviruses
COVID-19
Diabetes
Heart failure
Hyperlipidemia
Hypertension
Ischemia
Lung cancer
Medical imaging
Mortality
Oncology
Peptides
Risk factors
Side effects
Thyroid diseases
Vein & artery diseases
lung cancer
shared risk factors
cardiovascular disease
cancer treatment complications
multidisciplinary care
Online AccessGet full text

Cover

Abstract Cardiovascular disease (CVD) and lung cancer are among the leading causes of mortality worldwide, with a significant interplay that complicates patient management and treatment outcomes. This review explores the complex relationship between various forms of CVD - such as coronary artery disease, heart failure (HF), arrhythmias, and valvular heart disease - and lung cancer. Shared risk factors, including smoking, aging, and chronic inflammation, contribute to the co-occurrence of these conditions. Additionally, treatments for lung cancer, particularly chemotherapy and radiation therapy, can exacerbate CVD, necessitating a multidisciplinary approach to patient care. We delve into specific CVD-related impacts on lung cancer prognosis and vice versa, examining mechanisms, clinical outcomes, and management strategies. Our findings highlight the need for integrated care involving oncologists, cardiologists, and other healthcare providers to optimize treatment plans and improve patient outcomes. Emphasizing comprehensive cardiovascular risk management in lung cancer patients, we advocate for further research to deepen our understanding and develop novel therapeutic approaches, ultimately enhancing the quality of life and survival rates in patients suffering from both CVD and lung cancer.
AbstractList Cardiovascular disease (CVD) and lung cancer are among the leading causes of mortality worldwide, with a significant interplay that complicates patient management and treatment outcomes. This review explores the complex relationship between various forms of CVD - such as coronary artery disease, heart failure (HF), arrhythmias, and valvular heart disease - and lung cancer. Shared risk factors, including smoking, aging, and chronic inflammation, contribute to the co-occurrence of these conditions. Additionally, treatments for lung cancer, particularly chemotherapy and radiation therapy, can exacerbate CVD, necessitating a multidisciplinary approach to patient care. We delve into specific CVD-related impacts on lung cancer prognosis and vice versa, examining mechanisms, clinical outcomes, and management strategies. Our findings highlight the need for integrated care involving oncologists, cardiologists, and other healthcare providers to optimize treatment plans and improve patient outcomes. Emphasizing comprehensive cardiovascular risk management in lung cancer patients, we advocate for further research to deepen our understanding and develop novel therapeutic approaches, ultimately enhancing the quality of life and survival rates in patients suffering from both CVD and lung cancer.Cardiovascular disease (CVD) and lung cancer are among the leading causes of mortality worldwide, with a significant interplay that complicates patient management and treatment outcomes. This review explores the complex relationship between various forms of CVD - such as coronary artery disease, heart failure (HF), arrhythmias, and valvular heart disease - and lung cancer. Shared risk factors, including smoking, aging, and chronic inflammation, contribute to the co-occurrence of these conditions. Additionally, treatments for lung cancer, particularly chemotherapy and radiation therapy, can exacerbate CVD, necessitating a multidisciplinary approach to patient care. We delve into specific CVD-related impacts on lung cancer prognosis and vice versa, examining mechanisms, clinical outcomes, and management strategies. Our findings highlight the need for integrated care involving oncologists, cardiologists, and other healthcare providers to optimize treatment plans and improve patient outcomes. Emphasizing comprehensive cardiovascular risk management in lung cancer patients, we advocate for further research to deepen our understanding and develop novel therapeutic approaches, ultimately enhancing the quality of life and survival rates in patients suffering from both CVD and lung cancer.
Cardiovascular disease (CVD) and lung cancer are among the leading causes of mortality worldwide, with a significant interplay that complicates patient management and treatment outcomes. This review explores the complex relationship between various forms of CVD - such as coronary artery disease, heart failure (HF), arrhythmias, and valvular heart disease - and lung cancer. Shared risk factors, including smoking, aging, and chronic inflammation, contribute to the co-occurrence of these conditions. Additionally, treatments for lung cancer, particularly chemotherapy and radiation therapy, can exacerbate CVD, necessitating a multidisciplinary approach to patient care. We delve into specific CVD-related impacts on lung cancer prognosis and vice versa, examining mechanisms, clinical outcomes, and management strategies. Our findings highlight the need for integrated care involving oncologists, cardiologists, and other healthcare providers to optimize treatment plans and improve patient outcomes. Emphasizing comprehensive cardiovascular risk management in lung cancer patients, we advocate for further research to deepen our understanding and develop novel therapeutic approaches, ultimately enhancing the quality of life and survival rates in patients suffering from both CVD and lung cancer.
Cardiovascular disease (CVD) and lung cancer are among the leading causes of mortality worldwide, with a significant interplay that complicates patient management and treatment outcomes. This review explores the complex relationship between various forms of CVD - such as coronary artery disease, heart failure (HF), arrhythmias, and valvular heart disease - and lung cancer. Shared risk factors, including smoking, aging, and chronic inflammation, contribute to the co-occurrence of these conditions. Additionally, treatments for lung cancer, particularly chemotherapy and radiation therapy, can exacerbate CVD, necessitating a multidisciplinary approach to patient care. We delve into specific CVD-related impacts on lung cancer prognosis and vice versa, examining mechanisms, clinical outcomes, and management strategies. Our findings highlight the need for integrated care involving oncologists, cardiologists, and other healthcare providers to optimize treatment plans and improve patient outcomes. Emphasizing comprehensive cardiovascular risk management in lung cancer patients, we advocate for further research to deepen our understanding and develop novel therapeutic approaches, ultimately enhancing the quality of life and survival rates in patients suffering from both CVD and lung cancer.
Author Gulati, Amit
Diaz Saravia, Sara
Gupta, Soumya
Nagourney, Alexander
Choi, James
Tsyvkin, Elina
Silverman, Alexander
Katic, Luka
Torelli, Vincent
Glavan, Martina
Khurana, Sakshi
AuthorAffiliation 4 Radiology, New York Presbyterian-Columbia University Irving Medical Center, New York, USA
5 Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, USA
1 Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA
2 Neuroscience, Yale University, New Haven, USA
3 Cardiology, Icahn School of Medicine at Mount Sinai, New York, USA
AuthorAffiliation_xml – name: 3 Cardiology, Icahn School of Medicine at Mount Sinai, New York, USA
– name: 1 Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA
– name: 5 Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, USA
– name: 2 Neuroscience, Yale University, New Haven, USA
– name: 4 Radiology, New York Presbyterian-Columbia University Irving Medical Center, New York, USA
Author_xml – sequence: 1
  givenname: Luka
  surname: Katic
  fullname: Katic, Luka
  organization: Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA
– sequence: 2
  givenname: James
  surname: Choi
  fullname: Choi, James
  organization: Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA
– sequence: 3
  givenname: Sara
  surname: Diaz Saravia
  fullname: Diaz Saravia, Sara
  organization: Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA
– sequence: 4
  givenname: Alexander
  surname: Silverman
  fullname: Silverman, Alexander
  organization: Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA
– sequence: 5
  givenname: Alexander
  surname: Nagourney
  fullname: Nagourney, Alexander
  organization: Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA
– sequence: 6
  givenname: Vincent
  surname: Torelli
  fullname: Torelli, Vincent
  organization: Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA
– sequence: 7
  givenname: Soumya
  surname: Gupta
  fullname: Gupta, Soumya
  organization: Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA
– sequence: 8
  givenname: Martina
  surname: Glavan
  fullname: Glavan, Martina
  organization: Neuroscience, Yale University, New Haven, USA
– sequence: 9
  givenname: Amit
  surname: Gulati
  fullname: Gulati, Amit
  organization: Cardiology, Icahn School of Medicine at Mount Sinai, New York, USA
– sequence: 10
  givenname: Sakshi
  surname: Khurana
  fullname: Khurana, Sakshi
  organization: Radiology, New York Presbyterian-Columbia University Irving Medical Center, New York, USA
– sequence: 11
  givenname: Elina
  surname: Tsyvkin
  fullname: Tsyvkin, Elina
  organization: Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39044884$$D View this record in MEDLINE/PubMed
BookMark eNpdkc1Lw0AQxRdRrFZvniXgxYPV2c9sQBCtX4WCFz0vm81UU9JN3U0q_e9NbRX1NMO8H495vH2y7WuPhBxROE9TmV24NmAbzxXLJN8ie4wqPdBUi-1fe48cxjgFAAopgxR2SY9nIITWYo9cPr9hMvINhnlll8kNNh-IPhnaUJT1wkbXVjYkt2VEGzGxvkjGrX_tdO8wHJCdia0iHm5mn7zc3z0PHwfjp4fR8Ho8cBygGfCMie5DCsoCyqKA7swFQpaiFkLJHKly1lGeM3QTkDJnE62YxAxVkVPN--Rq7Ttv8xkWDn0TbGXmoZzZsDS1Lc1fxZdv5rVeGEqZkkyuHE43DqF-bzE2ZlZGh1VlPdZtNBy0AJZlmnboyT90WrfBd_lWlEpTCkx21NmacqGOMeDk5xsKZlWNWVdjvqrp8OPfCX7g7yL4J23ei3s
Cites_doi 10.1002/ejhf.1058
10.1097/CM9.0000000000002529
10.1093/annonc/mdl287
10.1080/14779072.2019.1691528
10.1186/s40425-017-0245-2
10.1155/2015/971453
10.1038/nrcardio.2014.211
10.1056/NEJM199707033370107
10.1016/j.blre.2019.03.005
10.1002/cam4.2183
10.3892/mco.2014.289
10.1007/s00330-014-3191-0
10.1093/icvts/ivab140
10.1016/S1470-2045(14)71180-5
10.36660/abc.20190201
10.1038/s41598-019-55060-7
10.1159/000196195
10.2214/AJR.10.5577
10.1016/s0735-1097(01)01788-0
10.1073/pnas.2200476119
10.1016/j.jacc.2020.03.001
10.36660/abc.20200478
10.3390/cancers15245723
10.1093/europace/euy268
10.1161/CIRCHEARTFAILURE.109.930701
10.1016/j.jaccao.2020.02.003
10.1002/jcp.28350
10.1016/j.cmpb.2015.12.024
10.1093/annonc/mdw640
10.15420/aer.2018:15:2
10.1097/00004872-200204000-00003
10.1164/rccm.201407-1395OC
10.1201/9781420006438
10.1056/NEJMsa1407211
10.1093/aje/kwu124
10.4065/mcp.2009.0706
10.1016/j.pcl.2005.10.004
10.1002/ejhf.1539
10.1161/CIRCULATIONAHA.120.047293
10.1016/s1010-7940(96)01097-4
10.1007/s00380-007-0979-8
10.1093/annonc/mdq042
10.1111/1759-7714.14174
10.3322/caac.21660
10.1016/0002-8703(83)90003-0
10.3390/jcm9051268
10.3978/j.issn.2072-1439.2011.02.03
10.1200/JCO.2007.10.9777
10.1136/heartjnl-2015-308765
10.1161/01.cir.0000025242.79963.4c
10.1177/10781552211004698
10.1161/CIRCEP.117.005443
10.1016/j.jacc.2019.07.079
10.11909/j.issn.1671-5411.2022.08.003
10.1371/journal.pone.0215246
10.1136/bmj.1.6107.210
10.1016/j.ccm.2019.10.001
10.1093/ehjqcco/qcac016
10.1097/00004872-200204000-00017
10.3389/fimmu.2022.871542
10.1186/1471-2407-6-129
10.1097/CRD.0b013e3182431c23
10.1093/icvts/ivu218
10.1177/1534735419869491
10.1016/j.cell.2020.04.034
10.1016/bs.vh.2017.05.007
10.1097/SLA.0000000000001626
10.1161/CIR.0000000000000986
10.1007/s10554-015-0664-4
10.21037/tlcr-22-493
10.2147/ITT.S125070
10.7150/ijbs.35460
10.1097/01.hjh.0000746336.69196.25
10.3389/fonc.2022.934369
10.1007/s00595-016-1355-z
10.1093/cvr/cvaa241
10.1038/nrendo.2012.99
10.1016/0735-1097(95)80037-h
10.1097/01.hjh.0000745076.39504.af
10.21037/jtd.2018.03.104
10.3390/biom13101490
ContentType Journal Article
Copyright Copyright © 2024, Katic et al.
Copyright © 2024, Katic et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright © 2024, Katic et al. 2024 Katic et al.
Copyright_xml – notice: Copyright © 2024, Katic et al.
– notice: Copyright © 2024, Katic et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright © 2024, Katic et al. 2024 Katic et al.
DBID NPM
AAYXX
CITATION
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
K9.
M0S
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.7759/cureus.62953
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
AUTh Library subscriptions: ProQuest Central
ProQuest One Community College
Coronavirus Research Database
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
Coronavirus Research Database
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed

Publicly Available Content Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X7
  name: Health & Medical Complete (ProQuest Database)
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2168-8184
ExternalDocumentID 10_7759_cureus_62953
39044884
Genre Journal Article
Review
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: P30 CA008748
GroupedDBID 3V.
53G
5VS
7X7
8FI
8FJ
ABUWG
ADBBV
ADRAZ
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
FYUFA
GROUPED_DOAJ
HMCUK
HYE
KQ8
M48
NPM
OK1
PGMZT
PIMPY
PQQKQ
PROAC
RPM
UKHRP
AAYXX
CITATION
7XB
8FK
AZQEC
COVID
DWQXO
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c300t-3924629106a0e5dd0c3034e097e84465be16cac13b2ecf055b2f8625e9e6db183
IEDL.DBID RPM
ISSN 2168-8184
IngestDate Tue Sep 17 21:28:00 EDT 2024
Fri Sep 27 17:22:48 EDT 2024
Thu Oct 10 22:31:46 EDT 2024
Fri Aug 23 04:59:22 EDT 2024
Wed Oct 23 09:54:06 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords lung cancer
shared risk factors
cardiovascular disease
cancer treatment complications
multidisciplinary care
Language English
License Copyright © 2024, Katic et al.
This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c300t-3924629106a0e5dd0c3034e097e84465be16cac13b2ecf055b2f8625e9e6db183
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11265258/
PMID 39044884
PQID 3086771025
PQPubID 2045583
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11265258
proquest_miscellaneous_3084029981
proquest_journals_3086771025
crossref_primary_10_7759_cureus_62953
pubmed_primary_39044884
PublicationCentury 2000
PublicationDate 2024-06-23
PublicationDateYYYYMMDD 2024-06-23
PublicationDate_xml – month: 06
  year: 2024
  text: 2024-06-23
  day: 23
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Palo Alto
– name: Palo Alto (CA)
PublicationTitle Curēus (Palo Alto, CA)
PublicationTitleAlternate Cureus
PublicationYear 2024
Publisher Cureus Inc
Cureus
Publisher_xml – name: Cureus Inc
– name: Cureus
References Ogawa H (ref56) 2021; 33
Maganti K (ref21) 2010; 85
Srinivasan NT (ref18) 2018; 7
Oser MG (ref23) 2015; 16
Eagle KA (ref12) 2002; 39
Kunimasa K (ref37) 2020; 2
Katic L (ref69) 2023; 13
Elhaj FA (ref13) 2016; 127
Kushnareva E (ref36) 2022; 13
Ahmed M (ref68) 2022; 119
Gujral DM (ref48) 2016; 102
Lee SY (ref78) 2002; 20
Carabello BA (ref22) 1997; 337
Blagus L (ref82) 2021; 39
Abravan A (ref45) 2022; 12
Osorio JC (ref77) 2017; 28
Upadhyay RK (ref7) 2015; 2015
Ball S (ref51) 2019; 74
Carver JR (ref5) 2007; 25
Zhao YW (ref28) 2022; 19
Cardinale D (ref54) 2016; 264
McGee K (ref65) 2021; 27
Li C (ref24) 2023; 136
Bade BC (ref25) 2020; 41
Zaborowska-Szmit M (ref38) 2020; 9
Zabłocka-Słowińska K (ref72) 2019; 14
Willemink MJ (ref44) 2015; 31
Filopei J (ref46) 2012; 20
Lazzerini PE (ref19) 2020; 142
Orthofer M (ref67) 2020; 181
de Boer RA (ref4) 2019; 21
Wit AL (ref14) 1983; 106
Jacobs PC (ref30) 2012; 198
Levenson B (ref2) 2020; 75
Tourmousoglou CE (ref32) 2014; 19
Voortman J (ref42) 2006; 6
Fradley MG (ref50) 2021; 144
Solomou E (ref83) 2019; 17
Doniger SJ (ref17) 2006; 53
Borlaug BA (ref11) 2010; 3
Sun M (ref29) 2022; 118
Glavic MM (ref81) 2021; 39
Kong M (ref59) 2021; 12
Cervantes-Madrid D (ref66) 2019; 9
van Hamersvelt RW (ref43) 2014; 24
Fineschi V (ref6) 2006
Chu G (ref53) 2019; 35
Joseph PG (ref16) 2021; 117
Carter BD (ref33) 2015; 372
Kanzaki R (ref31) 2017; 47
McCullough PA (ref9) 2002; 106
Buza V (ref49) 2017; 10
Nauta JF (ref10) 2017; 19
Yang Q (ref34) 2020; 114
von Lueder T (ref47) 2007; 22
Phelps CA (ref75) 2018; 106
Sahmoun AE (ref80) 2004; 24
Zipes DP (ref15) 2015; 12
Lin JJ (ref62) 2015; 191
Godwin JL (ref64) 2017; 5
Sung H (ref3) 2021; 71
Raisi-Estabragh Z (ref1) 2022; 9
Chen CF (ref41) 2018; 10
Zhuang X (ref26) 2019; 8
Raju S (ref27) 2018; 7
Albany C (ref76) 2011; 3
Stumpe KO (ref79) 2002; 20
Hardy D (ref35) 2010; 21
Vitols S (ref70) 1992; 52
Malakar AK (ref8) 2019; 234
Zipes DP (ref20) 1995; 26
Ratcliffe JG (ref73) 1978; 1
Hawryszko M (ref52) 2023; 15
Berghmans T (ref74) 2006; 17
Wang H (ref40) 2019; 15
Christensen AM (ref55) 2019; 21
Umeki S (ref71) 1993; 60
Zhang ZJ (ref60) 2014; 180
Ozerlat I (ref61) 2012; 8
Zhang M (ref58) 2014; 2
Yano T (ref39) 1997; 11
Shen Y (ref57) 2022; 11
Hung MS (ref63) 2019; 18
References_xml – volume: 19
  year: 2017
  ident: ref10
  article-title: What have we learned about heart failure with mid-range ejection fraction one year after its introduction?
  publication-title: Eur J Heart Fail
  doi: 10.1002/ejhf.1058
  contributor:
    fullname: Nauta JF
– volume: 136
  year: 2023
  ident: ref24
  article-title: Global burden and trends of lung cancer incidence and mortality
  publication-title: Chin Med J (Engl)
  doi: 10.1097/CM9.0000000000002529
  contributor:
    fullname: Li C
– volume: 17
  year: 2006
  ident: ref74
  article-title: Thyroid transcription factor 1--a new prognostic factor in lung cancer: a meta-analysis
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdl287
  contributor:
    fullname: Berghmans T
– volume: 17
  year: 2019
  ident: ref83
  article-title: Aortic wall stiffness as a side-effect of anti-cancer medication
  publication-title: Expert Rev Cardiovasc Ther
  doi: 10.1080/14779072.2019.1691528
  contributor:
    fullname: Solomou E
– volume: 5
  year: 2017
  ident: ref64
  article-title: Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer
  publication-title: J Immunother Cancer
  doi: 10.1186/s40425-017-0245-2
  contributor:
    fullname: Godwin JL
– volume: 2015
  year: 2015
  ident: ref7
  article-title: Emerging risk biomarkers in cardiovascular diseases and disorders
  publication-title: J Lipids
  doi: 10.1155/2015/971453
  contributor:
    fullname: Upadhyay RK
– volume: 12
  year: 2015
  ident: ref15
  article-title: Antiarrhythmic therapy in 2014: contemporary approaches to treating arrhythmias
  publication-title: Nat Rev Cardiol
  doi: 10.1038/nrcardio.2014.211
  contributor:
    fullname: Zipes DP
– volume: 337
  year: 1997
  ident: ref22
  article-title: Valvular heart disease
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199707033370107
  contributor:
    fullname: Carabello BA
– volume: 35
  year: 2019
  ident: ref53
  article-title: Atrial fibrillation and cancer - an unexplored field in cardiovascular oncology
  publication-title: Blood Rev
  doi: 10.1016/j.blre.2019.03.005
  contributor:
    fullname: Chu G
– volume: 52
  year: 1992
  ident: ref70
  article-title: Elevated uptake of low density lipoproteins by human lung cancer tissue in vivo
  publication-title: Cancer Res
  contributor:
    fullname: Vitols S
– volume: 8
  year: 2019
  ident: ref26
  article-title: Clinical features and therapeutic options in non-small cell lung cancer patients with concomitant mutations of EGFR, ALK, ROS1, KRAS or BRAF
  publication-title: Cancer Med
  doi: 10.1002/cam4.2183
  contributor:
    fullname: Zhuang X
– volume: 2
  year: 2014
  ident: ref58
  article-title: Association of serum hemoglobin A1c, C-peptide and insulin-like growth factor-1 levels with the occurrence and development of lung cancer
  publication-title: Mol Clin Oncol
  doi: 10.3892/mco.2014.289
  contributor:
    fullname: Zhang M
– volume: 24
  year: 2014
  ident: ref43
  article-title: Cardiac valve calcifications on low-dose unenhanced ungated chest computed tomography: inter-observer and inter-examination reliability, agreement and variability
  publication-title: Eur Radiol
  doi: 10.1007/s00330-014-3191-0
  contributor:
    fullname: van Hamersvelt RW
– volume: 33
  year: 2021
  ident: ref56
  article-title: Prognostic significance of preoperative haemoglobin A1c level in patients with lung adenocarcinoma
  publication-title: Interact Cardiovasc Thorac Surg
  doi: 10.1093/icvts/ivab140
  contributor:
    fullname: Ogawa H
– volume: 16
  year: 2015
  ident: ref23
  article-title: Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(14)71180-5
  contributor:
    fullname: Oser MG
– volume: 114
  year: 2020
  ident: ref34
  article-title: Chemotherapy-related anatomical coronary-artery disease in lung cancer patients evaluated by coronary-angiography SYNTAX score
  publication-title: Arq Bras Cardiol
  doi: 10.36660/abc.20190201
  contributor:
    fullname: Yang Q
– volume: 9
  year: 2019
  ident: ref66
  article-title: Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-55060-7
  contributor:
    fullname: Cervantes-Madrid D
– volume: 60
  year: 1993
  ident: ref71
  article-title: Decreases in serum cholesterol levels in advanced lung cancer
  publication-title: Respiration
  doi: 10.1159/000196195
  contributor:
    fullname: Umeki S
– volume: 198
  year: 2012
  ident: ref30
  article-title: Coronary artery calcium can predict all-cause mortality and cardiovascular events on low-dose CT screening for lung cancer
  publication-title: AJR Am J Roentgenol
  doi: 10.2214/AJR.10.5577
  contributor:
    fullname: Jacobs PC
– volume: 39
  year: 2002
  ident: ref12
  article-title: ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery)
  publication-title: J Am Coll Cardiol
  doi: 10.1016/s0735-1097(01)01788-0
  contributor:
    fullname: Eagle KA
– volume: 119
  year: 2022
  ident: ref68
  article-title: A hypothalamic pathway for Augmentor α-controlled body weight regulation
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.2200476119
  contributor:
    fullname: Ahmed M
– volume: 75
  year: 2020
  ident: ref2
  article-title: New ACC Global Heart Attack Treatment Initiative: improving STEMI care worldwide
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2020.03.001
  contributor:
    fullname: Levenson B
– volume: 118
  year: 2022
  ident: ref29
  article-title: Association between the severity of coronary artery disease and lung cancer: a pilot cross-sectional study
  publication-title: Arq Bras Cardiol
  doi: 10.36660/abc.20200478
  contributor:
    fullname: Sun M
– volume: 15
  year: 2023
  ident: ref52
  article-title: Cardiac arrhythmias in patients treated for lung cancer: a review
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers15245723
  contributor:
    fullname: Hawryszko M
– volume: 21
  year: 2019
  ident: ref55
  article-title: Clinical outcome in patients with implantable cardioverter-defibrillator and cancer: a nationwide study
  publication-title: Europace
  doi: 10.1093/europace/euy268
  contributor:
    fullname: Christensen AM
– volume: 3
  year: 2010
  ident: ref11
  article-title: Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction
  publication-title: Circ Heart Fail
  doi: 10.1161/CIRCHEARTFAILURE.109.930701
  contributor:
    fullname: Borlaug BA
– volume: 2
  year: 2020
  ident: ref37
  article-title: Cardiac adverse events in EGFR-mutated non-small cell lung cancer treated with osimertinib
  publication-title: JACC CardioOncol
  doi: 10.1016/j.jaccao.2020.02.003
  contributor:
    fullname: Kunimasa K
– volume: 234
  year: 2019
  ident: ref8
  article-title: A review on coronary artery disease, its risk factors, and therapeutics
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.28350
  contributor:
    fullname: Malakar AK
– volume: 127
  year: 2016
  ident: ref13
  article-title: Arrhythmia recognition and classification using combined linear and nonlinear features of ECG signals
  publication-title: Comput Methods Programs Biomed
  doi: 10.1016/j.cmpb.2015.12.024
  contributor:
    fullname: Elhaj FA
– volume: 28
  year: 2017
  ident: ref77
  article-title: Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdw640
  contributor:
    fullname: Osorio JC
– volume: 7
  year: 2018
  ident: ref18
  article-title: Sudden cardiac death and arrhythmias
  publication-title: Arrhythm Electrophysiol Rev
  doi: 10.15420/aer.2018:15:2
  contributor:
    fullname: Srinivasan NT
– volume: 20
  year: 2002
  ident: ref79
  article-title: Hypertension and the risk of cancer: is there new evidence?
  publication-title: J Hypertens
  doi: 10.1097/00004872-200204000-00003
  contributor:
    fullname: Stumpe KO
– volume: 191
  year: 2015
  ident: ref62
  article-title: Survival of patients with stage IV lung cancer with diabetes treated with metformin
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201407-1395OC
  contributor:
    fullname: Lin JJ
– year: 2006
  ident: ref6
  article-title: Pathology of the Heart and Sudden Death in Forensic Medicine
  doi: 10.1201/9781420006438
  contributor:
    fullname: Fineschi V
– volume: 372
  year: 2015
  ident: ref33
  article-title: Smoking and mortality--beyond established causes
  publication-title: N Engl J Med
  doi: 10.1056/NEJMsa1407211
  contributor:
    fullname: Carter BD
– volume: 180
  year: 2014
  ident: ref60
  article-title: Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwu124
  contributor:
    fullname: Zhang ZJ
– volume: 85
  year: 2010
  ident: ref21
  article-title: Valvular heart disease: diagnosis and management
  publication-title: Mayo Clin Proc
  doi: 10.4065/mcp.2009.0706
  contributor:
    fullname: Maganti K
– volume: 53
  year: 2006
  ident: ref17
  article-title: Pediatric dysrhythmias
  publication-title: Pediatr Clin North Am
  doi: 10.1016/j.pcl.2005.10.004
  contributor:
    fullname: Doniger SJ
– volume: 21
  year: 2019
  ident: ref4
  article-title: Cancer and heart disease: associations and relations
  publication-title: Eur J Heart Fail
  doi: 10.1002/ejhf.1539
  contributor:
    fullname: de Boer RA
– volume: 142
  year: 2020
  ident: ref19
  article-title: COVID-19, arrhythmic risk, and inflammation: mind the gap!
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.120.047293
  contributor:
    fullname: Lazzerini PE
– volume: 11
  year: 1997
  ident: ref39
  article-title: The current status of postoperative complications and risk factors after a pulmonary resection for primary lung cancer. A multivariate analysis
  publication-title: Eur J Cardiothorac Surg
  doi: 10.1016/s1010-7940(96)01097-4
  contributor:
    fullname: Yano T
– volume: 22
  year: 2007
  ident: ref47
  article-title: Rheumatic mitral valve stenosis mimicking advanced lung cancer
  publication-title: Heart Vessels
  doi: 10.1007/s00380-007-0979-8
  contributor:
    fullname: von Lueder T
– volume: 21
  year: 2010
  ident: ref35
  article-title: Cardiac toxicity in association with chemotherapy and radiation therapy in a large cohort of older patients with non-small-cell lung cancer
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdq042
  contributor:
    fullname: Hardy D
– volume: 12
  year: 2021
  ident: ref59
  article-title: Hemoglobin A1c level is a prognostic factor for locoregional recurrence in stage III non-small cell lung cancer patients treated with radiotherapy
  publication-title: Thorac Cancer
  doi: 10.1111/1759-7714.14174
  contributor:
    fullname: Kong M
– volume: 71
  year: 2021
  ident: ref3
  article-title: Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21660
  contributor:
    fullname: Sung H
– volume: 106
  year: 1983
  ident: ref14
  article-title: Pathophysiologic mechanisms of cardiac arrhythmias
  publication-title: Am Heart J
  doi: 10.1016/0002-8703(83)90003-0
  contributor:
    fullname: Wit AL
– volume: 9
  year: 2020
  ident: ref38
  article-title: Cardiovascular complications of systemic therapy in non-small-cell lung cancer
  publication-title: J Clin Med
  doi: 10.3390/jcm9051268
  contributor:
    fullname: Zaborowska-Szmit M
– volume: 3
  year: 2011
  ident: ref76
  article-title: Lung cancer, thyroid cancer or both: An unusual case presentation
  publication-title: J Thorac Dis
  doi: 10.3978/j.issn.2072-1439.2011.02.03
  contributor:
    fullname: Albany C
– volume: 25
  year: 2007
  ident: ref5
  article-title: American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2007.10.9777
  contributor:
    fullname: Carver JR
– volume: 102
  year: 2016
  ident: ref48
  article-title: Radiation-induced valvular heart disease
  publication-title: Heart
  doi: 10.1136/heartjnl-2015-308765
  contributor:
    fullname: Gujral DM
– volume: 106
  year: 2002
  ident: ref9
  article-title: B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study
  publication-title: Circulation
  doi: 10.1161/01.cir.0000025242.79963.4c
  contributor:
    fullname: McCullough PA
– volume: 27
  year: 2021
  ident: ref65
  article-title: A possible mechanism of hyperlipidemia in a patient with metastatic non-small cell lung cancer on lorlatinib therapy
  publication-title: J Oncol Pharm Pract
  doi: 10.1177/10781552211004698
  contributor:
    fullname: McGee K
– volume: 10
  year: 2017
  ident: ref49
  article-title: Cancer treatment-induced arrhythmias: focus on chemotherapy and targeted therapies
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.117.005443
  contributor:
    fullname: Buza V
– volume: 74
  year: 2019
  ident: ref51
  article-title: Cardiovascular toxicities of immune checkpoint inhibitors: JACC review topic of the week
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2019.07.079
  contributor:
    fullname: Ball S
– volume: 19
  year: 2022
  ident: ref28
  article-title: Inflammation-based different association between anatomical severity of coronary artery disease and lung cancer
  publication-title: J Geriatr Cardiol
  doi: 10.11909/j.issn.1671-5411.2022.08.003
  contributor:
    fullname: Zhao YW
– volume: 14
  year: 2019
  ident: ref72
  article-title: Oxidative stress in lung cancer patients is associated with altered serum markers of lipid metabolism
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0215246
  contributor:
    fullname: Zabłocka-Słowińska K
– volume: 1
  year: 1978
  ident: ref73
  article-title: Thyroid function in lung cancer
  publication-title: Br Med J
  doi: 10.1136/bmj.1.6107.210
  contributor:
    fullname: Ratcliffe JG
– volume: 41
  year: 2020
  ident: ref25
  article-title: Lung cancer 2020: epidemiology, etiology, and prevention
  publication-title: Clin Chest Med
  doi: 10.1016/j.ccm.2019.10.001
  contributor:
    fullname: Bade BC
– volume: 9
  year: 2022
  ident: ref1
  article-title: Temporal trends in disease-specific causes of cardiovascular mortality amongst patients with cancer in the USA between 1999 and 2019
  publication-title: Eur Heart J Qual Care Clin Outcomes
  doi: 10.1093/ehjqcco/qcac016
  contributor:
    fullname: Raisi-Estabragh Z
– volume: 20
  year: 2002
  ident: ref78
  article-title: Does hypertension increase mortality risk from lung cancer? A prospective cohort study on smoking, hypertension and lung cancer risk among Korean men
  publication-title: J Hypertens
  doi: 10.1097/00004872-200204000-00017
  contributor:
    fullname: Lee SY
– volume: 13
  year: 2022
  ident: ref36
  article-title: Case report: multiple causes of cardiac death after the first infusion of atezolizumab: histopathological and immunohistochemical findings
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2022.871542
  contributor:
    fullname: Kushnareva E
– volume: 6
  year: 2006
  ident: ref42
  article-title: Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-6-129
  contributor:
    fullname: Voortman J
– volume: 20
  year: 2012
  ident: ref46
  article-title: Radiation-induced heart disease
  publication-title: Cardiol Rev
  doi: 10.1097/CRD.0b013e3182431c23
  contributor:
    fullname: Filopei J
– volume: 19
  year: 2014
  ident: ref32
  article-title: Simultaneous occurrence of coronary artery disease and lung cancer: what is the best surgical treatment strategy?
  publication-title: Interact Cardiovasc Thorac Surg
  doi: 10.1093/icvts/ivu218
  contributor:
    fullname: Tourmousoglou CE
– volume: 18
  year: 2019
  ident: ref63
  article-title: Metformin prolongs survival in type 2 diabetes lung cancer patients with EGFR-TKIs
  publication-title: Integr Cancer Ther
  doi: 10.1177/1534735419869491
  contributor:
    fullname: Hung MS
– volume: 181
  year: 2020
  ident: ref67
  article-title: Identification of ALK in thinness
  publication-title: Cell
  doi: 10.1016/j.cell.2020.04.034
  contributor:
    fullname: Orthofer M
– volume: 106
  year: 2018
  ident: ref75
  article-title: Roles of thyroid transcription factor 1 in lung cancer biology
  publication-title: Vitam Horm
  doi: 10.1016/bs.vh.2017.05.007
  contributor:
    fullname: Phelps CA
– volume: 264
  year: 2016
  ident: ref54
  article-title: Prevention of atrial fibrillation in high-risk patients undergoing lung cancer surgery: the PRESAGE Trial
  publication-title: Ann Surg
  doi: 10.1097/SLA.0000000000001626
  contributor:
    fullname: Cardinale D
– volume: 144
  year: 2021
  ident: ref50
  article-title: Recognition, prevention, and management of arrhythmias and autonomic disorders in cardio-oncology: a scientific statement from the American Heart Association
  publication-title: Circulation
  doi: 10.1161/CIR.0000000000000986
  contributor:
    fullname: Fradley MG
– volume: 31
  year: 2015
  ident: ref44
  article-title: Prognostic value of heart valve calcifications for cardiovascular events in a lung cancer screening population
  publication-title: Int J Cardiovasc Imaging
  doi: 10.1007/s10554-015-0664-4
  contributor:
    fullname: Willemink MJ
– volume: 11
  year: 2022
  ident: ref57
  article-title: A retrospective study for prognostic significance of type II diabetes mellitus and hemoglobin A1c levels in non-small cell lung cancer patients treated with pembrolizumab
  publication-title: Transl Lung Cancer Res
  doi: 10.21037/tlcr-22-493
  contributor:
    fullname: Shen Y
– volume: 7
  year: 2018
  ident: ref27
  article-title: Review of checkpoint immunotherapy for the management of non-small cell lung cancer
  publication-title: Immunotargets Ther
  doi: 10.2147/ITT.S125070
  contributor:
    fullname: Raju S
– volume: 15
  year: 2019
  ident: ref40
  article-title: Radiation-induced heart disease: a review of classification, mechanism and prevention
  publication-title: Int J Biol Sci
  doi: 10.7150/ijbs.35460
  contributor:
    fullname: Wang H
– volume: 39
  year: 2021
  ident: ref82
  article-title: Estimated pulse wave velocity (EPWV) and mortality in subjects with healthy vascular ageing (HVA) and early vascular ageing (EVA) in general population. EH-UH Study
  publication-title: J Hypertens
  doi: 10.1097/01.hjh.0000746336.69196.25
  contributor:
    fullname: Blagus L
– volume: 12
  year: 2022
  ident: ref45
  article-title: Role of real-world data in assessing cardiac toxicity after lung cancer radiotherapy
  publication-title: Front Oncol
  doi: 10.3389/fonc.2022.934369
  contributor:
    fullname: Abravan A
– volume: 47
  year: 2017
  ident: ref31
  article-title: Outcomes of lung cancer surgery in patients with coronary artery disease: a decade of experience at a single institution
  publication-title: Surg Today
  doi: 10.1007/s00595-016-1355-z
  contributor:
    fullname: Kanzaki R
– volume: 117
  year: 2021
  ident: ref16
  article-title: Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153 152 middle-aged individuals
  publication-title: Cardiovasc Res
  doi: 10.1093/cvr/cvaa241
  contributor:
    fullname: Joseph PG
– volume: 8
  year: 2012
  ident: ref61
  article-title: Cancer: diabetes therapy and lung cancer
  publication-title: Nat Rev Endocrinol
  doi: 10.1038/nrendo.2012.99
  contributor:
    fullname: Ozerlat I
– volume: 24
  year: 2004
  ident: ref80
  article-title: Hypertension and risk of brain metastasis from small cell lung cancer: a retrospective follow-up study
  publication-title: Anticancer Res
  contributor:
    fullname: Sahmoun AE
– volume: 26
  year: 1995
  ident: ref20
  article-title: Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures), developed in collaboration with the North American Society of Pacing and Electrophysiology
  publication-title: J Am Coll Cardiol
  doi: 10.1016/0735-1097(95)80037-h
  contributor:
    fullname: Zipes DP
– volume: 39
  year: 2021
  ident: ref81
  article-title: Characteristics of healthy vascular ageing (HVA) and early vascular ageing (EVA) in general population. EH-UH Study (Croatian Scientific Foundation)
  publication-title: J Hypertens
  doi: 10.1097/01.hjh.0000745076.39504.af
  contributor:
    fullname: Glavic MM
– volume: 10
  year: 2018
  ident: ref41
  article-title: Effective cardiac radiotherapy relieved life-threatening heart failure caused by advanced small cell lung cancer with cardiac metastasis: a case report
  publication-title: J Thorac Dis
  doi: 10.21037/jtd.2018.03.104
  contributor:
    fullname: Chen CF
– volume: 13
  year: 2023
  ident: ref69
  article-title: Multifaceted roles of ALK family receptors and augmentor ligands in health and disease: a comprehensive review
  publication-title: Biomolecules
  doi: 10.3390/biom13101490
  contributor:
    fullname: Katic L
SSID ssj0001072070
Score 2.3136287
SecondaryResourceType review_article
Snippet Cardiovascular disease (CVD) and lung cancer are among the leading causes of mortality worldwide, with a significant interplay that complicates patient...
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage e62953
SubjectTerms Angina pectoris
Beta blockers
Cancer therapies
Cardiac arrhythmia
Cardiology
Cardiovascular disease
Cardioversion
Chronic illnesses
Congenital diseases
Coronary vessels
Coronaviruses
COVID-19
Diabetes
Heart failure
Hyperlipidemia
Hypertension
Ischemia
Lung cancer
Medical imaging
Mortality
Oncology
Peptides
Risk factors
Side effects
Thyroid diseases
Vein & artery diseases
SummonAdditionalLinks – databaseName: Coronavirus Research Database
  dbid: COVID
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LSwMxEB60gnjx_ahWWUGPW9M89gGCaLWoWL1Y6W3JZrMoyra23YP-eiebbbUVPHjdCSQ7M5lH5ssE4IhS5XtSpm5KQuJyKrkrU6lcqTj6Uyo9UlwUbt971x1-2xXd8sBtWMIqxzaxMNRJT5kz8hNGTOc1dIfirP_umlejTHW1fEJjHhZYgJlOBRaaD083l9-nLMSnqNQW8e77IjxR-UDnw7pHQ8GmfdGvAHMWJ_nD8bRWIBov2eJNXuv5KK6rz5lujv__p1VYLmNS59wq0RrM6WwdFttl1X0DTlGXHItOfJMfzoWFdjnNKSirc2lLPY7MEucOTQjSUaEGm9BpXT02r93y1QVXMUJGLgZMHLmDqaIkWiQJwc-MaxL6OjDd1WLd8JRUDRZTrVIiRExTTIuEDrWXxGghtqCS9TK9A07AmRezQMokUFzqMMb4LhVJIyUpY5I1qnA85n_Ut801IkxKjJwiK6eokFMVamP-ReUWG0bfzKvC4YSMm8NUPGSme3kxBvNjzChxqm0ry8lELCSYmga8CsGUlCcDTOPtaUr28lw04DbXrgQVwe7f69qDJYohkAGWUVaDymiQ630MYUbxQamnXxeh9bY
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS8MwFD7MCeKLeLc6pYI-dma59AKC6HQMcT452FtJ0xSF0Wm3gvv3nvQyrPrka5OQ8J0T8n3NyTkAF5Qqz5UycRISEIdTyR2ZSOVIxfE8pdIlxUPh0bM7HPPHiZi0oK42WgE4_1PamXpS42za_fxY3uCGR_7a9TwRXKk80_m869JAsDVYp5xx4-ujiugXf1uIR9G5y8j3X4OaZ9IvovkzXvLbATTYhq2KOdq3pal3oKXTXdgYVXfje3CNFrfLGMKpXNp3ZQCW3W8EnNr35YWMLdPYfsKNju1o9mwfxoOHl_7QqWojOIoRsnCQ1nBcOwo6SbSIY4KfGdck8LRvcqBFuucqqXosololRIiIJihehA60G0e4jw-gnc5SfQS2z5kbMV_K2Fdc6iBCFpaIuJeQhDHJehZc1uiE72UKjBClg0ExLFEMCxQt6NTQhbUdQ0ZMwjxkMcKC81UzurC5l5CpnuVFH1SxqPtwqsMS6dVELCAoIH1ugd-wwaqDSY_dbEnfXos02eZxlKDCP_7_0BPYpEhiTGgYZR1oL7JcnyIJWURnhX99ASGf4Hk
  priority: 102
  providerName: Scholars Portal
Title The Interplay Between Cardiovascular Disease and Lung Cancer
URI https://www.ncbi.nlm.nih.gov/pubmed/39044884
https://www.proquest.com/docview/3086771025
https://www.proquest.com/docview/3084029981/abstract/
https://pubmed.ncbi.nlm.nih.gov/PMC11265258
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bT8IwGP2CmBhfjHdRJDPRx0HpZZfEF7kFjSAxYnhbuq6LJDAIsAf_vd82RkDffFrSdmnz9TQ9Zz39BnBPqbItKUMzJC4xOZXclKFUplQc91MqLZJeFO71re6Qv4zEqABWfhcmNe0rf1yNJtNqNP5KvZXzqarlPrHaoNdMrr0IKpzaHuzZjG1p9PTLCrEpAjlzudu2cGsqXuh4WbWoK9ju_vOHVP72Rm5tNp1jOFqzROMpG80JFHR0Cge99Tn4GTzi7BqZX3Aiv41GZrYymjvmUqOVHb4YMgqMV1zUWI9TvDiHYaf90eya6_8gmIoRsjKRwnAcO4o3SbQIAoLFjGvi2tpJ8p35um4pqerMp1qFRAifhihUhHa1Ffi4Zi-gGM0ifQWGw5nlM0fKwFFcatdHxhWKoB6SkDHJ6iV4yKPjzbN0Fx7KhCSKXhZFL41iCcp56Lw16JceI0lyPGQsogR3m2qEa3IGISM9i9M2qFhR42FXl1mkNx0xl6BYdHgJnJ052DRIUmHv1iBC0pTYOSKu___qDRxSJCyJDYyyMhRXi1jfIuFY-RVE2ciuwH6j3R-847P59vncwtIedyop9n4AqK_eAg
link.rule.ids 230,315,733,786,790,891,2236,12083,21416,24346,27955,27956,31752,31753,33777,33778,38549,43343,43838,43928,53825,53827,74100,74657,74767
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDLZgSMCF92M8iwTHblkefUhICAZowAYXQNyqNE0FAnWwrQf49ThNNxhIHLjWkZLajh_xFwdgn1Lle1KmbkpC4nIquStTqVypOPpTKj1SXBTuXHutO375IB7KA7d-Casc2sTCUCddZc7I64yYzmvoDsXR65trXo0y1dXyCY1JmELHSoMKTDVv7i9Ov05ZiE9RqS3i3fdFWFd5T-f9mkdDwcZ90a8A8ydO8pvjOZ-HaLhkizd5ruWDuKY-fnRz_P8_LcBcGZM6x1aJFmFCZ0sw3Smr7stwiLrkWHTii3x3Tiy0y2mOQVmdU1vqcWSWOG00IUhHheqtwN352W2z5ZavLriKETJwkY8cuYOpoiRaJAnBz4xrEvo6MN3VYt3wlFQNFlOtUiJETFNMi4QOtZfEaCFWoZJ1M70OTsCZF7NAyiRQXOowxvguFUkjJSljkjWqcDDkf_Rqm2tEmJQYOUVWTlEhpypsDfkXlVusH30xrwp7IzJuDlPxkJnu5sUYzI8xo8Sp1qwsRxOxkGBqGvAqBGNSHg0wjbfHKdnTY9GA21y7ElQEG3-vaxdmWreddtS-uL7ahFmK4ZABmVG2BZVBL9fbGM4M4p1SZz8Bs9D4nQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LTxsxEB4VIiEuQB9AeLRbqRw3cfzYh4SEICHiXQ6l4rbyem21Am0gyR7g1zNeO6FJJU5c15bs9Yxn5vN8HgP8oFTFkZQmNCQlIaeSh9JIFUrF0Z9SGZH6ovDlVXRyw89uxa3nP408rXJiE2tDXQyUPSNvM2Irr6E7FG3jaRHXvf7Bw2NoX5CymVb_nMYCNDBEjhCINbo_f5_2Xk9cSExRwR37PY5F2lbVUFejVkRTwWb90n_B5jxn8h8n1F-Fu8n0HffkrlWN85Z6nqvs-D7_twYrPlYNDp1yfYQPuvwES5c-G_8Z9lHHAsdavJdPwZGjfAXdGYpr0HMpoECWRXCBpgXbUdGGX-Cmf_yrexL61xhCxQgZhxhIcVwphJCSaFEUBD8zrkka68RWXct1J1JSdVhOtTJEiJwahEtCpzoqcrQc67BYDkq9CUHCWZSzRMoiUVzqNMe4z4iiY4hhTLJOE_YmssgeXNGNDMGKlVnmZJbVMmvCzmQtM7_1RtnrQjbh-7QZN43NhMhSD6q6D-JmRJo41IaT63QglhKErAlvQjIj8WkHW5B7tqX8-6cuzG2vYwkqkq235_UNllC02cXp1fk2LFOMkiz3jLIdWBwPK72LUc44_-rV9wXKRgFv
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Interplay+Between+Cardiovascular+Disease+and+Lung+Cancer&rft.jtitle=Cur%C4%93us+%28Palo+Alto%2C+CA%29&rft.au=Katic%2C+Luka&rft.au=Choi%2C+James&rft.au=Diaz+Saravia%2C+Sara&rft.au=Silverman%2C+Alexander&rft.date=2024-06-23&rft.pub=Cureus&rft.eissn=2168-8184&rft.volume=16&rft.issue=6&rft_id=info:doi/10.7759%2Fcureus.62953&rft.externalDBID=PMC11265258
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2168-8184&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2168-8184&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2168-8184&client=summon